Literature DB >> 19941704

Nausea and vomiting of pregnancy: using the 24-hour Pregnancy-Unique Quantification of Emesis (PUQE-24) scale.

Neda Ebrahimi1, Caroline Maltepe1, Facundo Garcia Bournissen1, Gideon Koren1.   

Abstract

With up to 80% of pregnant women experiencing nausea and vomiting of pregnancy (NVP), it is critical to have a graded scale of its severity as a guide for appropriate treatment. In 2002 we introduced the Pregnancy-Unique Quantification of Emesis (PUQE) scoring system, which assessed the severity of nausea and vomiting in pregnancy (NVP) based on three physical symptoms: nausea, vomiting, and retching over the previous 12 hours. We present here validation of an extension of the original PUQE, by assessing NVP over 24 hours. This extension is deemed more clinically relevant, because assessment of symptoms over only 12 hours may encompass sleeping hours and hence may not adequately capture the length and severity of the symptoms. In this study we assessed the external validity of the new PUQE-24 by examining its ability to evaluate several characteristics associated with NVP: (a) ability to take multivitamin supplements; (b) rates of hospitalization and emergency room visits for severe symptoms; (c) sleep patterns; (d) liquid intake; and (e) the woman's self-rated well-being scores. Data collected prospectively from 315 women counselled via the Motherisk NVP line were used for the validation. PUQE-24 showed strong correlation with all parameters examined except for sleep patterns and hydration status. The well-being score, however, correlated significantly with hydration status. Capturing 24 hours rather than 12 hours of symptoms may better direct management of NVP and predict its outcome.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19941704     DOI: 10.1016/S1701-2163(16)34298-0

Source DB:  PubMed          Journal:  J Obstet Gynaecol Can        ISSN: 1701-2163


  29 in total

Review 1.  Nausea and vomiting of pregnancy.

Authors:  Noel M Lee; Sumona Saha
Journal:  Gastroenterol Clin North Am       Date:  2011-06       Impact factor: 3.806

2.  Comparison of Efficacy of Granisetron and Promethazine in Control of Hyperemesis Gravidarum.

Authors:  Ashraf Aleyasin; Elham Saffarieh; Hassan Torkamandi; Somayeh Hanafi; Fariborz Sadeghi; Atossa Mahdavi; Fatemeh Bahmaei; Mohammadreza Javadi
Journal:  J Obstet Gynaecol India       Date:  2015-10-07

Review 3.  Nausea and vomiting of pregnancy - What's new?

Authors:  Martha Bustos; Raman Venkataramanan; Steve Caritis
Journal:  Auton Neurosci       Date:  2016-05-13       Impact factor: 3.145

4.  Treatment of nausea and vomiting during pregnancy -a cross-sectional study among 712 Norwegian women.

Authors:  Kristine Heitmann; Anja Solheimsnes; Gro C Havnen; Hedvig Nordeng; Lone Holst
Journal:  Eur J Clin Pharmacol       Date:  2016-01-27       Impact factor: 2.953

Review 5.  Managing hyperemesis gravidarum: a multimodal challenge.

Authors:  J K Jueckstock; R Kaestner; I Mylonas
Journal:  BMC Med       Date:  2010-07-15       Impact factor: 8.775

6.  Review of NVP and HG and Early Pharmacotherapeutic Intervention.

Authors:  Shannon M Clark; Maged M Costantine; Gary D V Hankins
Journal:  Obstet Gynecol Int       Date:  2011-11-24

7.  Maternal safety of the delayed-release doxylamine and pyridoxine combination for nausea and vomiting of pregnancy; a randomized placebo controlled trial.

Authors:  Gideon Koren; Shannon Clark; Gary D V Hankins; Steve N Caritis; Jason G Umans; Menachem Miodovnik; Donald R Mattison; Ilan Matok
Journal:  BMC Pregnancy Childbirth       Date:  2015-03-18       Impact factor: 3.007

8.  The Leading Concerns of American Women with Nausea and Vomiting of Pregnancy Calling Motherisk NVP Helpline.

Authors:  Svetlana Madjunkova; Caroline Maltepe; Gideon Koren
Journal:  Obstet Gynecol Int       Date:  2013-04-15

9.  Preemptive treatment of nausea and vomiting of pregnancy: results of a randomized controlled trial.

Authors:  Caroline Maltepe; Gideon Koren
Journal:  Obstet Gynecol Int       Date:  2013-02-17

Review 10.  The delayed-release combination of doxylamine and pyridoxine (Diclegis®/Diclectin ®) for the treatment of nausea and vomiting of pregnancy.

Authors:  Svetlana Madjunkova; Caroline Maltepe; Gideon Koren
Journal:  Paediatr Drugs       Date:  2014-06       Impact factor: 3.022

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.